•  
  •  
  •  
  •  

2025-05-09 16:24:50

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Lemon Tree Hotels launches its 4th property in Goa with Lemon Tree Hotel, Anjuna
  • Route Mobile Ltd Q4 FY25 consolidated net profit falls to Rs. 56.58 crores
  • Star Housing Finance Ltd Q4 FY2024-25 PAT up at Rs. 2.97 crore
  • Linc Ltd Q4FY25 consolidated PAT higher at Rs. 12.10 crores
  • EKI Energy Services Ltd Q4 FY2025 consolidated loss at Rs. 6.24 crore

Keywords Selected:  USFDA

Stock Report

  • Senores Pharmaceuticals acquires ANDA for Topiramate HCl 25, 50, 100 and 200 mg tablets
  • Ichnos Glenmark Innovation receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma
  • Innoxel Lifesciences Pvt. Ltd. Successfully Completes U.S. FDA Inspection
  • Neuland Laboratories Ltd completes USFDA inspection at Unit 2
  • USFDA Inspection at Concord Biotech Ltd's API facility at Dholka
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg
  • Strides strengthens Anti-Inflammatory Portfolio with USFDA Approval for Celecoxib Capsules, 100 mg, 200 mg, and 400 mg
  • Gland Pharma receives approval from USFDA for Latanoprostene Bunod Opthalmic Solution
  • Zydus receives final approval from USFDA for Niacin Extended-Release Tablets USP, 500 mg, 750 mg, and 1,000 mg
  • USFDA inspection at manufacturing facility of Marksans Pharma's subsidiary Time-Cap Laboratories, Inc.
  • Closure of USFDA inspection at Zydus' API Unit at Dabhasa, Gujarat
  • India Glycols Limited receives EIR from USFDA for Dehradun Plant
  • Lupin receives approval from U.S. FDA for Tolvaptan Tablets
  • Eugia Pharma receives USFDA Approval for Dasatinib Tablets
  • Caplin Steriles Ltd gets USFDA approval for Phytonadione Injectable Emulsion
  • USFDA classifies Emcure Pharmaceuticals Ltd's API facility at Kurkumbh as VAI
  • J.B. Chemicals & Pharmaceuticals Ltd receives ANDA approval from USFDA for Bisoprolol Tablets USP
  • Update on USFDA inspection at manufacturing facility of Medispray in Kundaim, Goa, India
  • Lupin receives EIR from US FDA for its Injectable Facility in Nagpur
  • Alembic Pharmaceuticals receives USFDA Final Approval for Carbamazepine Tablets USP, 200 mg
  • Royal Sense Limited receives final approval from USFDA for products
  • Bliss GVS Pharma Ltd's partner gets final approval from USFDA for Mesalamine Suppositories 1000 mg
  • Laurus Labs Limited receives EIR for API facility Unit-4
  • Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg

Latest Post

  • Lemon Tree Hotels launches its 4th property in Goa with Lemon Tree Hotel, Anjuna
  • Route Mobile Ltd Q4 FY25 consolidated net profit falls to Rs. 56.58 crores
  • Star Housing Finance Ltd Q4 FY2024-25 PAT up at Rs. 2.97 crore
  • Linc Ltd Q4FY25 consolidated PAT higher at Rs. 12.10 crores
  • EKI Energy Services Ltd Q4 FY2025 consolidated loss at Rs. 6.24 crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024